The Netherlands
EV Biotech, founded in 2018, is revolutionizing the biotechnology landscape with its focus on microbial cell factory (MCF) strain development. From its headquarters in The Netherlands, the company leverages pioneering computational modeling—a nod to its slogan, "Accelerating Strain Development with smart use of models."
The company's distinct advantage lies in its sophisticated use of systems biology to craft computational models of bacterial strains. This innovation allows for predictive strain modifications and growth media supplementation, aligning with rational design strategies for enhanced efficiency. The synergy between its theoretical and experimental units ensures that models are swiftly updated, optimizing the development pipeline.
With an impressive €4.50M Seed Round secured on March 23, 2023, EV Biotech has drawn support from notable investors such as Blue Horizon and VOYAGERS.io, among others. These investments underscore confidence in the company’s potential to impact industries like biotechnology, food and beverage, nutrition, and wellness beauty.
